Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Santander Statement: Towards Global Convergence in Transplantation: Sufficiency, Transparency, and Oversight.
Participants to the Global Summit in Transplantation, organized by the Organización Nacional de Trasplantes under the Spanish Presidency of the Council of the European Union, the European Directorate for the Quality of Medicines and Healthcare−Council of Europe, the European Society for Organ Transplantation, and The Transplantation Society, co-sponsored by the World Health Organization and supported by the International Society of Nephrology in Santander, Spain, November 9 and 10, 2023. Participants to the Global Summit in Transplantation, organized by the Organización Nacional de Trasplantes under the Spanish Presidency of the Council of the European Union, the European Directorate for the Quality of Medicines and Healthcare−Council of Europe, the European Society for Organ Transplantation, and The Transplantation Society, co-sponsored by the World Health Organization and supported by the International Society of Nephrology in Santander, Spain, November 9 and 10, 2023. Transplantation. 2025 Jan 1;109(1):7-9. doi: 10.1097/TP.0000000000005286. Epub 2024 Dec 7. Transplantation. 2025. PMID: 39636761 No abstract available.
Supporting Financial Neutrality in Donation of Organs, Cells, and Tissues.
Martin DE, Capron AM, Fadhil RAS, Forsythe JLR, Padilla B, Pérez-Blanco A, Van Assche K, Bengochea M, Cervantes L, Forsberg A, Gracious N, Herson MR, Kazancioğlu R, Müller T, Noël L, Trias E, López-Fraga M. Martin DE, et al. Among authors: gracious n. Transplantation. 2025 Jan 1;109(1):48-59. doi: 10.1097/TP.0000000000005197. Epub 2024 Oct 22. Transplantation. 2025. PMID: 39437369
Toward Equity in Global Access to SoHO-based Therapies: Recommendations for Action.
Martin DE, Van Assche K, Cervantes L, Forsythe JLR, Muller T, Perez-Blanco A, Trias E, Bengochea M, Capron AM, Fadhil RAS, Forsberg A, Gracious N, Herson MR, Kazancioğlu R, Noel L, Padilla B, Lopez-Fraga M. Martin DE, et al. Among authors: gracious n. Transplantation. 2025 Jan 1;109(1):60-72. doi: 10.1097/TP.0000000000005106. Epub 2024 Oct 22. Transplantation. 2025. PMID: 39437368
Prevention of Trafficking in Organs, Tissues, and Cells.
Martin DE, Capron AM, Fadhil RAS, Forsythe JLR, Padilla B, Pérez-Blanco A, Van Assche K, Bengochea M, Cervantes L, Forsberg A, Gracious N, Herson MR, Kazancioğlu R, Müller T, Noël L, Trias E, López-Fraga M. Martin DE, et al. Among authors: gracious n. Transplantation. 2025 Jan 1;109(1):88-97. doi: 10.1097/TP.0000000000005212. Epub 2024 Oct 22. Transplantation. 2025. PMID: 39437366 Review.
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
Heerspink HJL, Agarwal R, Bakris GL, Cherney DZI, Lam CSP, Neuen BL, Sarafidis PA, Tuttle KR, Wanner C, Brinker MD, Dizayee S, Kolkhof P, Schloemer P, Vesterinen P, Perkovic V; FIND-CKD investigators. Heerspink HJL, et al. Nephrol Dial Transplant. 2024 Jun 11:gfae132. doi: 10.1093/ndt/gfae132. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 38858818
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Free PMC article. Clinical Trial.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Zhou Z, Jardine MJ, Li Q, Neuen BL, Cannon CP, de Zeeuw D, Edwards R, Levin A, Mahaffey KW, Perkovic V, Neal B, Lindley RI; CREDENCE Trial Investigators*. Zhou Z, et al. Stroke. 2021 May;52(5):1545-1556. doi: 10.1161/STROKEAHA.120.031623. Epub 2021 Apr 20. Stroke. 2021. PMID: 33874750 Free PMC article. Clinical Trial.
22 results